EMEA-002342-PIP01-18-M02
Key facts
| Invented name |
Verzenios
|
| Active substance |
abemaciclib
|
| Therapeutic area |
Oncology
|
| Decision number |
P/0440/2021
|
| PIP number |
EMEA-002342-PIP01-18-M02
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
Treatment of Ewing sarcoma
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Eli Lilly and Company Limited
E-mail: EU_PAEDIATRIC@LILLY.COM |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|